Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2018 | 2 |
2019 | 1 |
2024 | 0 |
Search Results
2 results
Results by year
Filters applied: . Clear all
Page 1
Quantifying the genetic risk for the development of axial spondyloarthropathy: could this become a diagnostic tool?
Curr Opin Rheumatol. 2018 Jul;30(4):319-323. doi: 10.1097/BOR.0000000000000517.
Curr Opin Rheumatol. 2018.
PMID: 29702496
Review.
The severity of ankylosing spondylitis and responses to anti-tumour necrosis factor biologics are not influenced by the tumour necrosis factor receptor polymorphism incriminated in multiple sclerosis.
Watts L, Karaderi T, Roberts A, Appleton L, Wordsworth T, Cohen C, Wordsworth P, Vecellio M.
Watts L, et al.
Genes Immun. 2019 Feb;20(2):167-171. doi: 10.1038/s41435-018-0017-0. Epub 2018 Mar 10.
Genes Immun. 2019.
PMID: 29535371
Item in Clipboard
Cite
Cite